Summary Although association of insulin-dependent diabetes mellitus with a haplotype at a locus encompassing the genes for insulin and the insulin-like growth factor II has been well established, two major studies disagree as to whether linkage to this locus is confined to paternally inherited alleles, or is present in alleles transmitted from either parental sex. Towards resolving this discrepancy, we examined parent-of-origin specific association rather than linkage, using the haplotype relative risk method in a mixed Caucasian population. We find that the haplotype relative risk (HRR) conferred by paternal chromosomes was much higher (5.1, p < 0.01) than the corresponding maternal value (2.3, p = 0.07), which narrowly failed to reach statistical significance. Thus, although we cannot exclude an effect of the maternal allele, such an effect appears to be considerably weaker. We review evidence that parental imprinting is genotype-dependent, which may explain the different degrees to which the paternal effect is seen in different populations. [Diabetologia (1995) 38: 715-719] Key words Genetic association, imprinting, insulin, insulin-like growth factor II.
ed haplotype common in the general population but even more common in diabetic patients, conferring a four-fold relative risk (RR). Linkage of this locus to IDDM was demonstrated in the original report [2] by finding that pairs of diabetic siblings shared one haplotype from heterozygous parents with a frequency of 0.67, significantly higher than the expected 0.5.
This transmission distortion was exclusively due to non-random sharing of haplotypes from heterozygous fathers (0.74 paternal, vs 0.54 maternal), suggesting that the susceptibility is transmitted by the paternal allele only. A more recent study in a British population questioned this parental effect, as pairs of diabetic siblings were found to share haplotypes at a frequency higher than 0.5, regardless of the sex of the heterozygous parent [4] .
In an effort to resolve this controversy we re-examined the question using association rather than linkage data: we evaluated the IDDM association with the INS-IGF2 locus by the haplotype relative risk method (HRR), an approach which eliminates the problem of population stratification in the study of genetic association. More importantl}; we describe a modification of the HRR method that permits examination of the effect of parental allele origin on disease-locus association to see whether the paternal effect on linkage, found in one of the studies, also applied to association.
Subjects, materials and methods
Subjects. Sixty-two 1DDM diabetic subjects and their parents were recruited through the Diabetic Clinic of the Montr6al Children's Hospital. The population was Caucasian and mostly of European descent, with French Canadians being the largest single group (approximately one-third). Diagnosis of IDDM was based on hyperglycaemia and ketonuria before age 18 years. Informed consent was obtained, and the study was approved by the hospital review board.
Polymorphism. The IDDM-associated region at 11 p 15.5 extends over 4.1 kb and consists of several polymorphisms at tight linkage disequilibrium. For the purpose of this study, we focused on a cluster of three RFLPs (Fig. 1) at the 3' end of INS, where association seems to be maximal [2, 3] , and which are always concordant for the presence of IDDM-associated alleles [3, 4, and our own observations]. Our data were generated using the PstI site, but the other two sites gave identical information in our patients, as they did in previous studies [3, 4] . Approximately 55 % of unselected Caucasian subjects are homozygous for the absence of the site, compared to 80-85 % of diabetic patients [3, 4] .
The RFLP was tested by polymerase chain reaction (PCR) as described by Bain et al. [4] . The cycling protocol was 94 ~ for 30 s, 60~ at 45 s, and 72~ at 90 s, in the presence of 2 mmol/l Mg ++. The PCR product was digested with PstI and resolved on an 8 % polyacrylamide gel.
In the families where the diabetic child and both parents were heterozygous, assignment of parental origin of each allele was made based on haplotypes using two RFLPs at the IGF2 gene (ApaI at the 3' untranslated region [5] and AluI on exon 3 [3] ) which are within 30 kb from the PstI site but not at linkage disequilibrium with it. The short physical distance between the three markers, corresponding to a small fraction of one cM, allowed us to assume absence of recombination in the four families in which this method was successfully used. In three families no assignment of parental origin could be made. We were, therefore, able to examine 59 families.
Statistical analysis
The HRR method evaluates genetic association with no need for control subjects from the general population. This is accomplished by comparing the two parental alleles that are transmitted to the affected offspring from unaffected parents with the two that are not [6] [7] [8] . The latter can be thought of as equivalent to the genotype of an unselected control individual. The advantage of the HRR method is that it eliminates the possibility that the inevitable differences between recruiting procedures for patients and control subjects result in genetic differences between the two groups (population stratification).
As previously proposed [6, 7] , the method compares the two transmitted and the two non-transmitted haplotypes together. It can be shown to be equally valid when haplotypes from the parent of each sex are separately examined. Thus, if 
Although this formula requires prospective data, it can be transformed, as discussed by Fleiss [9] , for application to casecontrol studies:
where P(+ rD) is the probability of having a paternally transmitted high-risk haplotype if affected with the disease, and P(+) the frequency of that haplotype in the general population. If P(D), the prevalence of the disease, is reasonably low, then P(+) can be reliably estimated by the frequency of (+) among paternal haplotypes not transmitted to the affected offspring. Thus, an estimate of the RR, based on N affected offspring can be obtained by the odds ratio (OR):
where T(+) and T(-) is the number of, respectively, high and low risk paternal haplotypes transmitted to the child. The identical reasoning can, of course, be applied to maternal alleles in separate calculations. These computations require no assumption about mode of inheritance or the presence of HardyWeinberg equilibrium.
Sample size. Preliminary data in our population, very similar to those found in case-control studies [3, 4] , showed a frequency of the protective (-) allele of approximately 0.1 in transmitted, and 0.3 in non-transmitted chromosomes, conferring an HRR of approximately 4. In order to detect this difference in the parent-specific studies at the 0.05 level with a power of 95 %, 111 data points are required (Table A3 in [9] ). Our sample slightly exceeded this requirement (59 x 2 = 118 paternal and 118 maternal alleles).
Results
The percentage of (+/+) homozygotes among our IDDM patients was very close to that reported in the French and British studies [2] [3] [4] , as were our derived control genotype frequencies compared to the CL, Confidence limits population control subjects in those studies ( Table 1) . The relative risk of 3.3 was also quite comparable. Table 2 compares transmission of the two alleles by parental sex. Transmission of paternal (-) alleles to diabetic offspring was 0.19 (4/21), significantly different from the expected 0.5 (p = 0.007 by comparison to a binomial distribution). The corresponding maternal rate was 0.33, not significantly different from 0.5. The same information is derived by comparing the two parent-specific, Yates-corrected [9] , ORs. The maternal value is much lower and not statistically significant. The paternal and maternal 2 x 2 tables were then subjected to the heterogeneity test of Woolf, as proposed by Gart [10] . The chi-square for the heterogeneity test was 1.25, which is not significant. This is not unexpected since, although the magnitude of the departure of transmission of maternal alleles from the expected value of 0.5 is not significant, the direction of the departure is in the same direction as that seen for paternal alleles. Therefore, this result does not allow us to rule out an effect of the maternal alleles, but we can conclude that the resulting maternal OR is less than the level of 4, targeted by our sample size.
Discussion
Our results provide independent confirmation of IDDM association with the INS-IGF2 locus in a mixed North American Caucasian population. The main problem with association studies in such a context is population stratification, i.e. the possibility that patients and control subjects do not share the same genetic background. Even matching for ethnicity, as was done in the British study [4] , does not necessarily protect from such an artifact. Our study is the first to demonstrate this association by the HRR method which eliminates this drawback by using as controls parental alleles that had exactly the same probability of being transmitted to the affected child as those that were actually transmitted. Furthermore, our analysis of allele transmission by parental sex is consistent with the paternal effect found by Julier et al. [2] . The predominant role of paternal alleles may be related to the observation that IDDM is inherited more often from a diabetic father than from a diabetic mother [11] , and suggests parental imprinting of the gene(s) involved.
Parental imprinting involves differential behaviour of the two copies of certain autosomal genes, depending on parental sex of origin [12] . We have shown that IGF2 is one of the few human genes known to be imprinted, with exclusive expression from the paternal copy [13] . This would favour IGF2 as the gene involved in the IDDM association. INS, the only other gene involved in the association, was found to have exclusive paternal expression in mouse yolk sack but not pancreas [14] . INS is likely also expressed from both alleles in human pancreas, as is seen at the protein level in carriers of mutant insulin peptides [15] . IGF2 is expressed by lymphocytes [16] and pancreatic beta cells [17] and may have important paracrine effects modulating the autoimmune process of IDDM.
On the other hand, in a sib-pair analysis in British IDDM subjects, Bain et al. [4] found significant distortion of haplotype sharing regardless of parental sex, thus questioning the imprinting effect. These authors speculated that genetic differences between the populations studied may account for the discrepancy. Indeed, experimental evidence from studies of parental imprinting of transgenes indicate that, in mice, the imprinting process is genotype-dependent [18, 19] . We have presented evidence of a similar variation in homo sapiens in the imprinting of IGF2R, the gene encoding the IGF-II receptor [20] . Differences between the French and British in the prevalence of allelic forms of genes controlling imprinting might explain the discrepancy.
Our paper presents a novel usage of the HRR method for detection and quantitation of parental imprinting effects in the genetics of human disease.
To address the same question, Julier et al. [2] and Bain et al. [4] examined parental effects on linkage by evaluating the frequency at which haplotypes from the parent of each sex are shared by diabetic siblings. Our method evaluates parental effects on association rather than on linkage, and we believe that it has the following advantages: first, affected sibling pairs are not required, an important advantage in disorders less common than IDDM. Second, it gives a meaningful quantitative result, estimating the relative risk of having the phenotype if one carries the associated allele in the chromosome derived from the parent of each sex. This may be important in estimating risk-benefit ratios in preventive interventions (immunosuppression, nicotinamide). Third, in calculating risk, it does not waste information, as all cases are taken into consideration, not only those with heterozygous parents.
The one a priori drawback of the method is that it can only be used in the presence of a known association: a specific allele of the marker locus must be at linkage disequilibrium with the disease-predisposing allele. In the association examined here, disease and marker loci are actually genetically indistinguishable [21] . At present the method is most useful in evaluating associations with precisely defined loci, such as those identified by the candidate gene approach. However, the rapidly improving resolution of human genome maps, currently an average of 0.7 cM [22] , will make it increasingly likely to find linkage disequilibrium of anonymous markers with less well defined susceptibility loci, such as those identified by genome-wide linkage searches. At the same time, as imprinting is better understood and imprinted domains of the genome are defined, there will be a greater demand for formal tools, similar to the approach presented here, for detection and C. Polychronakos et al.: Paternal effect in IDDM susceptibility quantitation of its effects in the genetics of human disease.
